Table 3.
N-BPs Form |
Size nm |
Cellular Biodistribution |
In Vivo Biodistribution |
In Vitro Functional Effects |
In Vivo Functional Effects |
Ref. |
---|---|---|---|---|---|---|
Free alendronic acid or free zoledronic acid |
NA | Passive penetration and inhibition of FPPS, Generation of IPP and DMAPP |
High plasma and renal excretion (min) and high bone concentration and release along time half-life (years) |
Anti-tumor toxic effects triggering Vδ2 T cells |
Potent anti-osteoporotic Effects Use for bone metastasis treatment |
reviewed in [200] |
high phase-transition phospholipids, cholesterol and pegylated liposomes for alendronic acid |
85–100 nm Neg charged |
High cellular penetration | High Plasma half-life (18 h) Low renal excretion High extraskeletal tissue |
Anti-tumor toxic effects triggering Vδ2 T cells |
Murine models Anti-tumor effects Synergistic effects with Vδ2 T cell administration |
[200,209,210,211] |
high phase-transition phospholipids, cholesterol and pegylated liposomes for zoledronic acid |
85–100 nm Neg charged |
High cellular penetration | High Plasma half-life (18 h) Low renal excretion High extraskeletal tissue |
Anti-tumor toxic effects triggering Vδ2 T cells |
Murine models anti-tumor effects and sudden death |
[200,209,210,211] |
ZOL-containing self-assembly PEGylated nanoparticles (NPs) or ZOL-encapsulating PEGylated liposomes DOTAP/chol/DSPE-PEG |
147–245 nm +1.8–17.5 mV ζ pot |
Not performed specific studies | Not performed specific studies | Not performed specific studies | Potent anticancer effect in murine model of prostate adenocarcinoma | [212] |
PEGylated ZOL- charged NPs with CaPZ NPs and DOTAP/chol/DSPEG2000 | 147 nm +18 mv ζ pot |
Strong effects on mesenchymal stromal cells and tumor cells | Not performed specific studies | Not performed specific studies | Not performed specific studies | [213] |
Spheric polymeric nanoparticles DPPC:DSPE-PEG7.5:2.5 molar ratiocharged with zol |
171 nm –43 mV ζpot |
Penetration and generation of IPP in tumor cells and Mo, no toxicity on Mo |
Not assessed as Zol charged NPs |
Potent boost of Vδ2 T cell proliferation and cytolysis of 3D CRC spheroids and patient-derived organoids | Not assessed as Zol charged NPs Potent antitumor effects on orthotopic glioblastoma multiforme in murine models as docetaxel- and diclofenac-charged NPs |
[214,215] |
Abbreviations: FPPS: farnesyl pyrophosphate synthase; IPP: isopentenyl pyrophosphate; DMAPP: Dimethyl-allil pyrophosphate; DPPC:DSPE-PEG: 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[succinyl(polyethylene glycol)-2000] (DSPE-PEG),DOTAP: 1,2-dioleoyl-3-trimethylammonium-propane chloride. Mo: monocytes; CRC: colorectal carcinoma.